UA98899U - Method for treating patients with chronic obstructive pulmonary disease combined with ischemic heart disease - Google Patents
Method for treating patients with chronic obstructive pulmonary disease combined with ischemic heart diseaseInfo
- Publication number
- UA98899U UA98899U UAU201412881U UAU201412881U UA98899U UA 98899 U UA98899 U UA 98899U UA U201412881 U UAU201412881 U UA U201412881U UA U201412881 U UAU201412881 U UA U201412881U UA 98899 U UA98899 U UA 98899U
- Authority
- UA
- Ukraine
- Prior art keywords
- chronic obstructive
- obstructive pulmonary
- pulmonary disease
- ischemic heart
- treating patients
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Спосіб лікування хворих на хронічне обструктивне захворювання легень у поєднанні з ішемічною хворобою серця включає базову терапію, а саме: лікування хронічного обструктивного захворювання легень (β-агоністи, антихолінергічні препарати, метилксантини, глюкокортикостероїди та інгібітори фосфодіестерази-4) та ішемічної хвороби серця (антитромбоцитарні перапарати, β-адреноблокатори, інгібітори АПФ). Додатково застосувають настоянки ехінацеї та хлорофіліпту всередину: ехінацеї по 30 крапель зранку і вдень та хлорофіліпту по 5 мл 1 % спиртового розчину, розведеного 30 мл води 3 рази на добу за 40 хвилин до прийому їжі.The method of treatment of patients with chronic obstructive pulmonary disease in combination with coronary heart disease includes basic therapy, namely: treatment of chronic obstructive pulmonary disease (β-agonists, anticholinergic drugs, methylxanthines, glucocorticosteroids and inhibitors of phosphatetherobi and phytosteroids and phosphatherocytestrobi , β-blockers, ACE inhibitors). In addition, apply tinctures of echinacea and chlorophyllip inside: echinacea 30 drops in the morning and afternoon and chlorophyllipto 5 ml of 1% alcohol solution diluted with 30 ml of water 3 times a day for 40 minutes before meals.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201412881U UA98899U (en) | 2014-12-01 | 2014-12-01 | Method for treating patients with chronic obstructive pulmonary disease combined with ischemic heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201412881U UA98899U (en) | 2014-12-01 | 2014-12-01 | Method for treating patients with chronic obstructive pulmonary disease combined with ischemic heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA98899U true UA98899U (en) | 2015-05-12 |
Family
ID=53674766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201412881U UA98899U (en) | 2014-12-01 | 2014-12-01 | Method for treating patients with chronic obstructive pulmonary disease combined with ischemic heart disease |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA98899U (en) |
-
2014
- 2014-12-01 UA UAU201412881U patent/UA98899U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123460T1 (en) | COMPOUNDS AND METHODS FOR TREATING AN EPILEPSY DISORDER | |
| EA201500934A1 (en) | CARDIO AND NEPHROPROTECTIVE ANTI-DIABETIC THERAPY | |
| WO2015054619A3 (en) | Use of a pcsk9 inhibitor to treat hyperlipidemia | |
| BR112017007144A2 (en) | valproic acid or a pharmaceutically acceptable salt thereof, compound, pharmaceutical composition, and, compound or composition for use, use, method or composition. | |
| CY1121628T1 (en) | SALTS IT AND METHODS OF USE | |
| AR101740A1 (en) | COMBINATION AND COMPOSITION THERAPY | |
| WO2016090024A3 (en) | Combination therapy for treatment of cancer | |
| CY1123501T1 (en) | USE OF RESLIZUMAB IN THE TREATMENT OF MODERATE TO SEVERE EOSINOPHILIC ASTHMA | |
| BR112015027477A8 (en) | bolus, its uses, and kit | |
| AR111374A1 (en) | USE OF LIK066 IN PATIENTS WITH HEART FAILURE | |
| BR112015010039A2 (en) | treatment of cancer with pomalidomide in an individual with renal dysfunction | |
| EA201691385A1 (en) | Combined Cancer Therapy | |
| EA201891007A1 (en) | AIMING FOR FORMILPEPTID RECEPTOR 2 / LIPOXIN A RECEPTOR (FPR2 / ALX) FOR TREATING HEART DISEASES | |
| UY37534A (en) | METHOD FOR THE TREATMENT OF FIBROTIC DISEASES USING INTERFERON-LAMBDA | |
| AR103118A1 (en) | ANAMORELINE-BASED MEDICAL TREATMENTS | |
| AR109012A1 (en) | TRANSDERMAL ADMINISTRATION SYSTEM CONTAINING GALANTAMINE OR SALTS OF THIS | |
| EA201500765A1 (en) | METHODS OF TREATING CARDIOVASCULAR DISEASES | |
| UA98899U (en) | Method for treating patients with chronic obstructive pulmonary disease combined with ischemic heart disease | |
| Estenkova et al. | About the spa and resort-based treatment of the patients with oncological diseases | |
| ES2537905B2 (en) | Use of 12-deoxiforboles to promote the proliferation of neural stem cells | |
| UA109966C2 (en) | METHOD OF TREATMENT OF LATENT ISCHEMIC HEART DISEASE IN PATIENTS WITH Bronchial asthma | |
| DOP2014000258A (en) | TREATMENT OF THE METALASIS IN THE BRAIN WITH A COMBINATION OF VELIPARIB AND A THERAPY WITH RADIATION IN THE TOTALITY OF THE BRAIN | |
| Guevara | Adalimumab/etanercept | |
| TH154826A (en) | Esketamine for treating depression that is resistant to treatment or is unresponsive to treatment | |
| PL419074A1 (en) | Medical application of magnoflorine |